99 related articles for article (PubMed ID: 20421532)
1. Role of molecular subtype in predicting outcome of AIDS-related diffuse large B-cell lymphoma.
Dunleavy K; Wilson WH
J Clin Oncol; 2010 Jun; 28(16):e260; author reply e261-2. PubMed ID: 20421532
[No Abstract] [Full Text] [Related]
2. [HIV-related non-Hodgkin lymphoma in 45 patients; a retrospective analysis].
Kersten MJ; Mertens MJ; Pals ST; Reiss P; van Oers MH
Ned Tijdschr Geneeskd; 1993 Jul; 137(28):1396-400. PubMed ID: 8345893
[TBL] [Abstract][Full Text] [Related]
3. Non-Hodgkin's lymphoma: treatment of large cell lymphomas.
Armitage JO; Carde P; Wolf M
Rev Invest Clin; 1994 Apr; Suppl():83-8. PubMed ID: 7886316
[No Abstract] [Full Text] [Related]
4. The prognosis of HIV-infected patients with diffuse large B-cell lymphoma treated with chemotherapy and highly active antiretroviral therapy is similar to that of HIV-negative patients receiving chemotherapy.
Navarro JT; Lloveras N; Ribera JM; Oriol A; Mate JL; Feliu E
Haematologica; 2005 May; 90(5):704-6. PubMed ID: 15921395
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of cyclophosphamide, adriamycin, vincristine, prednisone and rituximab in patients with human immunodeficiency virus-associated diffuse large B-cell lymphoma: results of a phase II trial.
Ribera JM; Oriol A; Morgades M; González-Barca E; Miralles P; López-Guillermo A; Gardella S; López A; Abella E; García M;
Br J Haematol; 2008 Feb; 140(4):411-9. PubMed ID: 18162120
[TBL] [Abstract][Full Text] [Related]
6. State-of-the-art therapeutics: diffuse large B-cell lymphoma.
Coiffier B
J Clin Oncol; 2005 Sep; 23(26):6387-93. PubMed ID: 16155024
[TBL] [Abstract][Full Text] [Related]
7. Immuno-fluorescence in situ hybridization index predicts survival in patients with diffuse large B-cell lymphoma treated with R-CHOP: a GELA study.
Copie-Bergman C; Gaulard P; Leroy K; Briere J; Baia M; Jais JP; Salles GA; Berger F; Haioun C; Tilly H; Emile JF; Banham AH; Mounier N; Gisselbrecht C; Feugier P; Coiffier B; Molina TJ
J Clin Oncol; 2009 Nov; 27(33):5573-9. PubMed ID: 19786664
[TBL] [Abstract][Full Text] [Related]
8. Non-Hodgkin's lymphoma and acquired immune deficiency syndrome (AIDS). A case report.
Plemons JM; Benton E; Rankin KV
Tex Dent J; 2005 Jul; 122(7):658-64. PubMed ID: 16152890
[No Abstract] [Full Text] [Related]
9. Prognostic factors in HIV-related diffuse large-cell lymphoma: before versus after highly active antiretroviral therapy.
Lim ST; Karim R; Tulpule A; Nathwani BN; Levine AM
J Clin Oncol; 2005 Nov; 23(33):8477-82. PubMed ID: 16230675
[TBL] [Abstract][Full Text] [Related]
10. Patients with HIV with Burkitt's lymphoma have a worse outcome than those with diffuse large-cell lymphoma also in the highly active antiretroviral therapy era.
Spina M; Simonelli C; Talamini R; Tirelli U
J Clin Oncol; 2005 Nov; 23(31):8132-3; author reply 8133-4. PubMed ID: 16258119
[No Abstract] [Full Text] [Related]
11. AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy.
Lim ST; Karim R; Nathwani BN; Tulpule A; Espina B; Levine AM
J Clin Oncol; 2005 Jul; 23(19):4430-8. PubMed ID: 15883411
[TBL] [Abstract][Full Text] [Related]
12. Detection of somatic quantitative genetic alterations by multiplex polymerase chain reaction for the prediction of outcome in diffuse large B-cell lymphomas.
Jardin F; Ruminy P; Kerckaert JP; Parmentier F; Picquenot JM; Quief S; Villenet C; Buchonnet G; Tosi M; Frebourg T; Bastard C; Tilly H
Haematologica; 2008 Apr; 93(4):543-50. PubMed ID: 18287131
[TBL] [Abstract][Full Text] [Related]
13. Diffuse large B-cell lymphoma on the back of a patient with AIDS: successful treatment by the CD20 monoclonal antibody rituximab.
Voigtländer C; Harrer T; Schneider L; Schulze-Koops H; Niedobitek G; Lüftl M
Int J Dermatol; 2005 Nov; 44(11):976-8. PubMed ID: 16336543
[No Abstract] [Full Text] [Related]
14. Plasma TNF-alpha and IL-10 level-based prognostic model predicts outcome of patients with diffuse large B-Cell lymphoma in different risk groups defined by the International Prognostic Index.
Lech-Maranda E; Bienvenu J; Broussais-Guillaumot F; Warzocha K; Michallet AS; Robak T; Coiffier B; Salles G
Arch Immunol Ther Exp (Warsz); 2010 Apr; 58(2):131-41. PubMed ID: 20191326
[TBL] [Abstract][Full Text] [Related]
15. [Clinical characteristics and prognosis of diffuse large B-cell lymphoma].
Yang BY; Yong WB; Zhu J; Zheng W; Zhang YT; Wang XP; Meng SN
Zhonghua Zhong Liu Za Zhi; 2005 Mar; 27(3):174-6. PubMed ID: 15946571
[TBL] [Abstract][Full Text] [Related]
16. The International Prognostic Index can be used as a guide to treatment decisions regarding patients with human immunodeficiency virus-related systemic non-Hodgkin lymphoma.
Rossi G; Donisi A; Casari S; Re A; Cadeo G; Carosi G
Cancer; 1999 Dec; 86(11):2391-7. PubMed ID: 10590382
[TBL] [Abstract][Full Text] [Related]
17. Can rituximab change the usually dismal prognosis of patients with intravascular large B-cell lymphoma?
Ferreri AJ; Dognini GP; Govi S; Crocchiolo R; Bouzani M; Bollinger CR; D'Incan M; Delaporte E; Hamadani M; Jardin F; Martusewicz-Boros M; Montanari M; Szomor A; Zucca E; Cavalli F; Ponzoni M
J Clin Oncol; 2008 Nov; 26(31):5134-6; author reply 5136-7. PubMed ID: 18838697
[No Abstract] [Full Text] [Related]
18. HIV-related large B-cell lymphoma confined to the bone marrow with a fulminant clinical course: a case report and literature review.
Moore D; Cohen P; Malik S
Clin Adv Hematol Oncol; 2007 Aug; 5(8):622-4; discussion 625-6. PubMed ID: 17982403
[No Abstract] [Full Text] [Related]
19. Presence of a high-grade component in gastric mucosa-associated lymphoid tissue (MALT) lymphoma is not associated with an adverse prognosis.
Ang MK; Hee SW; Quek R; Yap SP; Loong S; Tan L; Tao M; Lim ST
Ann Hematol; 2009 May; 88(5):417-24. PubMed ID: 18777110
[TBL] [Abstract][Full Text] [Related]
20. Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma.
Boué F; Gabarre J; Gisselbrecht C; Reynes J; Cheret A; Bonnet F; Billaud E; Raphael M; Lancar R; Costagliola D
J Clin Oncol; 2006 Sep; 24(25):4123-8. PubMed ID: 16896005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
